Funded by National Institutes of Health and National Institute on Aging
R01 AG068183 (Babulal, PI)
09/15/2020 – 05/31/2025
Naturalistic driving as a functional neurobehavioral marker of preclinical and symptomatic Alzheimer disease
The goal of this project is to examine whether naturalistic driving can distinguish persons with and without preclinical AD among cognitively normal individuals and if driving behavior can improve prediction of incident cognitive impairment and dementia.
R01 AG067428 (Babulal, PI)
06/15/2020 – 03/31/2025
The Impact of Depression and Preclinical Alzheimer Disease on Driving Among Older Adults
The goal of this project is to examine whether major depression and preclinical AD, combined, predict faster longitudinal change in driving behavior among older adults, and assess the impact of medications (antidepressants), major depression, and preclinical AD on naturalistic driving.
R01 AG056466 (Babulal, PI)
08/01/2017 – 05/31/2023
Preclinical Alzheimer Disease and Driving
The goal of this research is to determine whether preclinical AD predicts cross-sectional differences and longitudinal changes in naturalistic driving and to identify driving, biomarker, clinical, physical, and behavioral predictors of driving cessation, and to develop predictive models using these variables.
Funded by the BrightFocus Foundation
A2021142S(Babulal, PI)
09/01/2020 – 08/31/2023
Using naturalistic driving behavior as a digital, neurobehavioral marker to predict those at risk for preclinical and symptomatic Alzheimer disease